It has not been an ideal start to the 2024 NFL season for New York Giants wide receiver Jalin Hyatt. The second-year receiver has had limited action thus ...
Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...